Research ExplorerPublicationsCirculating levels of cell adhesion molecule L1 as a prognos...

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.

Standard

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients. / Zander, Hilke; Rawnaq, Tamina; von Wedemeyer, Max; Tachezy, Michael; Kunkel, Miriam; Wolters, Gerrit; Bockhorn, Maximilian; Schachner, Melitta; Izbicki, Jakob R.; Kaifi, Jussuf.

In: BMC CANCER, Vol. 11, 2011, p. 1-7.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Zander, H, Rawnaq, T, von Wedemeyer, M, Tachezy, M, Kunkel, M, Wolters, G, Bockhorn, M, Schachner, M, Izbicki, JR & Kaifi, J 2011, 'Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.', BMC CANCER, vol. 11, pp. 1-7. https://doi.org/10.1186/1471-2407-11-189

APA

Zander, H., Rawnaq, T., von Wedemeyer, M., Tachezy, M., Kunkel, M., Wolters, G., Bockhorn, M., Schachner, M., Izbicki, J. R., & Kaifi, J. (2011). Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients. BMC CANCER, 11, 1-7. https://doi.org/10.1186/1471-2407-11-189

Vancouver

Zander H, Rawnaq T, von Wedemeyer M, Tachezy M, Kunkel M, Wolters G et al. Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients. BMC CANCER. 2011;11:1-7. https://doi.org/10.1186/1471-2407-11-189

Bibtex

@article{a68942dfbf4644a8be13e0bf7ffe4670,
title = "Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.",
abstract = "L1 cell adhesion molecule (CD171) is expressed in many malignant tumors and its expression correlates with unfavourable outcome. It thus represents a target for tumor diagnosis and therapy. An earlier study conducted by our group identified L1 expression levels in primary gastrointestinal stromal tumors (GIST) as a prognostic marker. The aim of the current study was to compare L1 serum levels of GIST patients with those of healthy controls and to determine whether levels of soluble L1 in sera could serve as a prognostic marker.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Prognosis, Survival Analysis, Retrospective Studies, Recurrence, Case-Control Studies, Tumor Markers, Biological/*blood, Gastrointestinal Stromal Tumors/blood/*diagnosis/mortality, Neural Cell Adhesion Molecule L1/*blood, Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Prognosis, Survival Analysis, Retrospective Studies, Recurrence, Case-Control Studies, Tumor Markers, Biological/*blood, Gastrointestinal Stromal Tumors/blood/*diagnosis/mortality, Neural Cell Adhesion Molecule L1/*blood",
author = "Hilke Zander and Tamina Rawnaq and {von Wedemeyer}, Max and Michael Tachezy and Miriam Kunkel and Gerrit Wolters and Maximilian Bockhorn and Melitta Schachner and Izbicki, {Jakob R.} and Jussuf Kaifi",
year = "2011",
doi = "10.1186/1471-2407-11-189",
language = "English",
volume = "11",
pages = "1--7",
journal = "BMC CANCER",
issn = "1471-2407",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.

AU - Zander, Hilke

AU - Rawnaq, Tamina

AU - von Wedemeyer, Max

AU - Tachezy, Michael

AU - Kunkel, Miriam

AU - Wolters, Gerrit

AU - Bockhorn, Maximilian

AU - Schachner, Melitta

AU - Izbicki, Jakob R.

AU - Kaifi, Jussuf

PY - 2011

Y1 - 2011

N2 - L1 cell adhesion molecule (CD171) is expressed in many malignant tumors and its expression correlates with unfavourable outcome. It thus represents a target for tumor diagnosis and therapy. An earlier study conducted by our group identified L1 expression levels in primary gastrointestinal stromal tumors (GIST) as a prognostic marker. The aim of the current study was to compare L1 serum levels of GIST patients with those of healthy controls and to determine whether levels of soluble L1 in sera could serve as a prognostic marker.

AB - L1 cell adhesion molecule (CD171) is expressed in many malignant tumors and its expression correlates with unfavourable outcome. It thus represents a target for tumor diagnosis and therapy. An earlier study conducted by our group identified L1 expression levels in primary gastrointestinal stromal tumors (GIST) as a prognostic marker. The aim of the current study was to compare L1 serum levels of GIST patients with those of healthy controls and to determine whether levels of soluble L1 in sera could serve as a prognostic marker.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Prognosis

KW - Survival Analysis

KW - Retrospective Studies

KW - Recurrence

KW - Case-Control Studies

KW - Tumor Markers, Biological/blood

KW - Gastrointestinal Stromal Tumors/blood/diagnosis/mortality

KW - Neural Cell Adhesion Molecule L1/blood

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Prognosis

KW - Survival Analysis

KW - Retrospective Studies

KW - Recurrence

KW - Case-Control Studies

KW - Tumor Markers, Biological/blood

KW - Gastrointestinal Stromal Tumors/blood/diagnosis/mortality

KW - Neural Cell Adhesion Molecule L1/blood

U2 - 10.1186/1471-2407-11-189

DO - 10.1186/1471-2407-11-189

M3 - SCORING: Journal article

VL - 11

SP - 1

EP - 7

JO - BMC CANCER

JF - BMC CANCER

SN - 1471-2407

ER -